Avantax Advisory Services Inc. Decreases Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Avantax Advisory Services Inc. lowered its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 10.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,565 shares of the company’s stock after selling 1,464 shares during the period. Avantax Advisory Services Inc.’s holdings in Privia Health Group were worth $246,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. FMR LLC boosted its holdings in shares of Privia Health Group by 1.5% during the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after purchasing an additional 271,645 shares during the period. Riverbridge Partners LLC lifted its holdings in Privia Health Group by 19.7% in the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after buying an additional 958,418 shares during the period. Geode Capital Management LLC grew its position in shares of Privia Health Group by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock worth $43,986,000 after buying an additional 23,178 shares during the last quarter. Franklin Resources Inc. increased its stake in shares of Privia Health Group by 2.2% during the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after buying an additional 28,480 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Privia Health Group by 6.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,133,873 shares of the company’s stock valued at $22,167,000 after buying an additional 69,649 shares during the period. Institutional investors own 94.48% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on PRVA shares. Stephens reiterated an “overweight” rating and issued a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. JPMorgan Chase & Co. boosted their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Canaccord Genuity Group raised their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, February 28th. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 price objective on shares of Privia Health Group in a research report on Friday, March 21st. Finally, Piper Sandler raised their target price on Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $26.67.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $22.88 on Thursday. The company has a market capitalization of $2.76 billion, a price-to-earnings ratio of 228.82, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.04. The company’s 50-day moving average is $23.77 and its 200 day moving average is $21.12.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.